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Introduction 
 
Atherosclerotic diseases are a major cause of 
morbidity and mortality worldwide. Among the 
classic risk factors known, elevated levels of 
low density lipoprotein cholesterol (LDL-C), 
and reduced levels of high density lipoprotein 
cholesterol (HDL-C) are associated with a 
significant increase in the incidence of 
atherosclerotic cardiovascular disease. 
HDL are a family of heterogeneous particles 
that vary in size, density and chemical composi-
tion as a result of their rates of synthesis and 
catabolism and of continuous intravascular re-
modeling by the action of enzymes and trans-
port proteins (1).  
Plasma HDL concentration is modulated by 
both environmental and genetic factors. Find-
ings from several studies suggest that polymor-
phisms at the hepatic lipase (HL), apolipo-
protein AI/CIII/AIV, and cholesteryl ester 
transfer protein genes are major sources of 
genetically determined variation in plasma 
HDL-C concentrations (2). Notably, allelic 
variations at the HL gene account for up to 25% 
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of the variability in plasma HDL-C concentra-
tions (2).  
Hepatic Lipase (HL), a glycoprotein member of 
the lipase super family, plays an important role 
in the metabolism and modeling of both pro- 
and anti atherogenic lipoproteins. Synthesized 
and secreted by the liver, HL carries out several 
metabolic functions, including the hydrolysis of 
triglycerides, the lipolysis of phospholipids, the 
modeling of small, dense atherogenic LDL par-
ticles, and the catabolism of HDL (3). 
The human hepatic lipase gene (LIPC), located 
on chromosome 15q21, and is 35kb in size, 
with 9 exons spans >120 kb of DNA and en-
codes a protein with 449 amino acids (4). 
The C→T base pair substitution at Position-514 
is associated with up to 30% reduction in 
promoter activity in vitro (5-7), marked de-
creased plasma HL activity, and increased con-
centrations of plasma HDL, HDL2, and large 
buoyant LDL particles. The association be-
tween -514C/T polymorphisms in LIPC gene 
with the serum HDL-C levels was demonstrated. 
(8-10).   
Thus, there is considerable evidence of associa-
tions between promoter polymorphisms of the 
HL gene and HL activity and plasma lipoprotein 
concentrations. The C-514T polymorphism of 
LIPC gene is not associated with CHD 
susceptibility (11). However, the effects of the 
LIPC genotype on atherosclerosis have been 
controversial (12).  
With this background, the present study investi-
gated the effects of LIPC promoter -514 C→T 
polymorphism on coronary atherosclerosis inpa-
tients in Tabriz city in Iran. 
 
Materials and Methods 
 
Subjects 
A total of 342 unrelated patients with possible 
coronary heart stenosis ages 17-80 years (mean 
54 years) attending the specialist clinics at the 
Emam Reza and Shahid madani hospitals in 
Tabriz, Iran were studied. All subjects under-
went coronary angiography. The coronary 
angiograms were classified as non CAD, steno-
sis of one vessel (1VD), 2 vessels (2VD) and 3 
vessels (3VD). 
Data for body mass index (BMI), smoking his-
tory, blood pressure, diabetes status and lipid 
profile were collected. Hypertension was consi-
dered to be present if systolic blood pressure 
was >140 mmHg or diastolic blood pressure 
>90 mmHg and any antihypertensive treatment 
had been instituted. Diabetes mellitus was diag-
nosed if fasting plasma glucose was >120 
mg/dl .Smoking status was defined as non-
smokers, low smokers ( <10 cigarettes/day), 
and ex smoker( > 10 cigarettes/day).  
The inclusion criteria were the presence of 
chest pain whose required angiographic 
examination.  Those of receiving lipid lowering 
drugs or having a history of coronary bypass 
surgery, diabetes, hepatic or renal failure (se-
rum creatinine > 2.0 mg/dl) and uncontrolled 
hypothyroidism, or neoplasias were excluded 
from the study. 
Informed consent was obtained from patients 
and the study was approved by the Tabriz 
University of Medical Sciences Ethical 
Committee. 
 
Blood sampling and biochemical determina-
tions  
Blood samples were collected early in the 
morning after an overnight fast in glass tubes. 
Glucose, total cholesterol (TC), triglycerides 
(TG), HDL-C (direct method) and LDL-C (di-
rect method) were determined by standard 
enzymatic procedures using commercial kits 
(Pars Azmon Co). Apolipoprotein A1 (Apo A1) 
and Apolipoprotein B (Apo B) levels were 
measured by immunoturbidimeteric method 
(Pars Azmon Co). Creatinine is measured with 
Jaffe method for exclude renal patients. 
 
Genotyping of hepatic lipase gene polymor-
phism 
DNA was extracted from 1 ml EDTA-contain-
ing blood using phenol-chlorophorm method. 
Amplification of a 711-bp promoter region of 
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the hepatic lipase gene was carried out by 
polymerase chain reaction (PCR) with 50 ng 
genomic DNA and 10 pmol of each 
oligonucleotide primers (F: 5'-GGAT-
CACCTCTCAATGGGTC -3', and R: 5'-
ACCTGGTTTCAGGCTTTGTC-3') in 25 µl. 
PCR was performed at 96 ˚C for 5 min fol-
lowed by 36 cycles of denaturation at 95 ˚C for 
45 sec, annealing at 60 ˚C for 1 min, and exten-
sion at 72 ˚C for 1 min. 
The PCR products (10 µl) were then digested 
with 5 units of restriction enzyme NlaIII in a 
total volume of 20 µl as recommended by the 
manufacture (Fermentas canada). Digested 
products were separated by electrophoresis on a 
6% non-denaturing polyacrylamide gel at 200 
V for 2 h. and visualized by silver staining 
procedure (Fig. 1).  
 
Statistical analysis 
Frequency distributions of characteristics of 
studied subjects were examined according to 
LIPC genotype. Chi-square tests were used to 
compare the genotypes. Due to small number of 
TT genotype (n =17) and absence of any 
significant differences between CT and TT 
genotypes regarding HDL-C concentrations, we 
considered CT and TT genotype as a group. 
All values are expressed as means ± S.D. unless 
otherwise noted. ANOVA was used to analyze 
the differences in plasma lipid, ApoA and 
ApoB levels.  When statistically significant ef-
fects were demonstrated, Turkey’s post-hoc test 
was used to identify between-group differences. 
In order to adjust for sex, age, hypertension, 
BMI and smoking, we employed a general li-
near model.  
 Statistical analyses were carried out using the 
SPSS statistical package (SPSS, 11.5). Statis-
tical significance was assessed at the 5% level 
of probability. 
 
Results 
 
A total of 342 subjects were investigated, from 
which 196 individuals were found to be af-
fected with CAD based on coronary angiogra-
phy procedure. Among the all subjects, 222 
carriers of the CC genotype, 103 of the CT 
genotype and 17 of the TT genotype of the 
LIPC promoter gene were identified. This study 
revealed a T allele frequency of 0.221 and 
0.150 in males and females respectively (Table 
1). The interaction between LIPC genotypes 
and CAD groups is represented in Table 2. 
Statistical analysis failed to show any overall 
relationship between the -514C/T polymor-
phisms and CAD groups. Also values of the 
CAD groups were similar among the 3 geno-
type groups. 
The characteristics of the subjects according to 
the –514C/T polymorphism are shown in Table 
3. To investigate the effects LIPC promoter 
polymorphisms on lipid profile, we compared 
two subgroups LIPC genotype CC compared 
with genotype CT/TT.   
No significant differences were found between 
subjects with the CC genotype and those with 
the CT/TT genotype concerning total choles-
terol, triglyceride, ApoA1.ApoB, LDL-C, BMI, 
and age. Finally, a significant association was 
found between T allele and HDL-C concentra-
tion in men group (Table 4). 
 
 
 
Fig. 1: Representative polyacrylamide gel electrophoresis 
picture of -514C/T. Lane 1 is DNA marker, lane2 and 5 
and 6 and 10 are related to the CC genotype, lane3 and 8 
and 9 are related to the CT genotype, lane 4 and 7 are 
related to the TT genotype. Lane 11 is negative control 
(without DNA), Lane 12 is DNA control (without en-
zyme)
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Table 1:  Genotype distribution and allele frequency of -514 C >T polymorphism 
between  male and female groups 
% Frequency (number) Genotype Men                      Women                   Total 
CC                            62.4(151)              71(71)                     64.9(222) 
CT                             31(75)                   28(28)                    30.1(103) 
      TT                             6.6(16)                  1(1)                        5(17) 
        T allele                       0.221                     0.150                     0.211 
 
Table 2: Characteristics of the subjects according to LIPC genotype and CAD status 
 Genotype non CAD           1VD           2VD        3VD          Total 
             Female * 
CC                                      43                   11                9              8                71 
CT                                      16                     4                4              4                28 
TT                                        0                     1                0              0                 1 
Total                                   59                   16              13            12             100 
               Male ** 
CC                                      55                  27               35           34              151 
CT                                      25                  21               15           14                75 
TT                                        7                     1                 2             6               16 
Total                                  87                   49              52            54               242 
             * P Value is 0.752     **P Value is 0.466 
              CAD; coronary artery disease, 1VD; stenosis of one vessel, 2VD; stenosis of 2 vessels, 3VD; stenosis of 3  vessels.     
P< 0.05 is significant 
 
Table 3: Characteristics of the subjects according to LIPC genotype status 
Parameter                              CC(n=222)                 CT&TT(n=120)             P Value 
Age[ year]                                  53.2±10.7                       54.7±10.0                    0.25 
BMI  [kg/m2]                              27.0±4.0                        26.7±3.8                       0.58 
Apo A-I [mg/dl]                       123.6±19.0                     124.1±21.4                    0.84 
Apo B100 [mg/dl]                      103.7±26.5                     103.3±3                         0.90 
Total Cholesterol [mg/dl]        172.7±40.9                      177.2±50.1                   0.43 
Triglyceride [mg/dl]                 196.9±100.9                   174.1±94.8                   0.07 
HDL-C [mg/dl]                           36.3±9.6                         39.3±12.1                   0.02 
LDL-C [mg/dl]                          95.1±33.3                        96.6±35.1                   0.73 
P< 0.05 is significant 
BMI, Body Mass Index; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density 
lipoprotein cholesterol,  Apo A-I; Apolipoprotein A-I, Apo B100 ; Apolipoprotein B100 
 
Table 4: HDL-C concentration in subjects according to LIPC genotype status and gender 
HDL-C( mg/dl) -514C/T n Mean± SD  P Value 
CC 151 34.8±9.1 Male CT&TT 91 38.61±10.8 0.01 
CC 71 39.7±10.0 Female CT&TT 29 41.5±15.6 0.54 
CC 222 36.3±9.6 Total CT&TT 120 39.3±12.2 0.02 
          P< 0.05 is significant 
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Discussion 
 
The present study investigated the effects of -
514 C→T, LIPC polymorphism on lipid profile 
in subjects with coronary arteries stenosis. This 
polymorphism was detected in about 36% of 
patients with angiographically established coro-
nary artery disease and in about 33% of non 
CAD control subjects (Table 1). 
This study revealed a T allele frequency of 
0.226, 0.136 and 0.223, 0.170 for non CAD 
(males and females) and CAD (males and fe-
males) respectively. These finding are in agree-
ment with previously reported T allele fre-
quency in Caucasians (13, 14).  
It has been suggested that HL may modulate the 
development of cardiovascular disease through 
its catalytic activity and independently of ligand 
-binding function pathways (15). In addition, 
HL has been identified to be present in the ves-
sel wall where it modulates atherogenic risk in 
apoE-deficient and lecithin-cholesterol acyl 
transferase transgenic mice (16).  These mul-
tiple functions of HL, which facilitate not only 
plasma lipid metabolism but also cellular lipid 
uptake,can be anticipated to have a major and 
complex impact on atherogenesis. Therefore, 
the C-514T HL polymorphism   may confer 
atherosclerosis susceptibility by affecting HL 
synthesis and activity. However, no significant 
difference was founded concerning T allele fre-
quency in non CAD and CAD groups in this 
study (P=0.752 and P= 0.466 for women and 
men respectively). There is ample evidence to 
demonstrate that HL affects both HDL choles-
terol and triglyceride-rich lipoproteins (17, 18). 
It can be postulated that TT genotype with low 
HL activity could changed production of preβ 
HDL and delivery of HDL -C to the liver (19). 
We didn’t find any statistical significance in 
other heart risk factors in CC and CT&TT 
genotype in our study groups , therefore we 
suggest substitution C→T in -514 of LIPC 
don’t  change the heart risk factors (Table 3).  
Very few data are available concerning the rela-
tion between the LIPC -514C→T polymor-
phism and plasma HDL-C concentrations 
among patients with coronary artery stenosis.  
In this study, serum HDL-C concentration was 
found to be higher among men subjects with T 
allele (Table 4).  These findings are in consis-
tent with literature documenting elevated 
plasma HDL-cholesterol concentration in 
association with the T allele among the general 
white population (20-23). 
It has been widely accepted that such an 
association is likely to be mediated by a reduc-
tion in HL activity induced by the- 514 T allele. 
In vitro studies reported upto30% reduction in 
promoter activity attributed to the C→T base 
substitution (24, 25). The role of HL in the 
metabolism of HDL is well recognized (9). The 
association of T allele with HDL-C levels in a 
specific Gender may be due to differences in 
sex hormones which may differentially mod-
ulate lipoprotein metabolism or HL activity   
between males and females. The gender differ-
ence in HL activity has led some to hypothesize 
that HL activity is a major determinant of the 
more atherogenic. Lipoprotein profile in men 
compared with women. Moreover As HL activ-
ity is regulated by sex- steroid hormones which 
are presented in higher level in men than in 
women , the -514C→T of LIPC gene may 
cause further reduction of HL activity in men , 
leading to denser HDL-C concentration (Table 
4).  
In conclusion, these data demonstrate two find-
ings. First, there was a significant association of 
T allele with HDL-C concentration in men 
groups and second there was no difference at T 
allele frequency in non CAD and CAD groups. 
 
Abbreviations 
 BMI, body mass index; CAD coronary artery 
disease; HDL, high-density lipoprotein; HDL-C, 
HDL cholesterol; LDL, low-density lipo-
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protein; LDL-C, LDL cholesterol; LIPC, hu-
man hepatic lipase gene. 
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